First Time Loading...
B

Biotoxtech Co Ltd
KOSDAQ:086040

Watchlist Manager
Biotoxtech Co Ltd
KOSDAQ:086040
Watchlist
Price: 5 750 KRW 2.5% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

Price Targets Summary
Biotoxtech Co Ltd

Wall Street analysts forecast Biotoxtech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Biotoxtech Co Ltd is 15 000 KRW .

Lowest
Price Target
Not Available
Average
Price Target
15 000 KRW
161% Upside
Highest
Price Target
Not Available
Biotoxtech Co Ltd Competitors:
Price Targets
OABI
OmniAb Inc
121% Upside
LONN
Lonza Group AG
10% Upside
603127
Joinn Laboratories China Co Ltd
28% Upside
4YL
Nanoform Finland Oyj
83% Upside
RVTY
Revvity Inc
28% Upside
PPGN
PolyPeptide Group AG
27% Downside
GSS
Genetic Signatures Ltd
2% Upside
ABSI
Absci Corp
69% Upside

Revenue
Forecast

Revenue Estimate
Biotoxtech Co Ltd

For the last 8 years the compound annual growth rate for Biotoxtech Co Ltd's revenue is 9%. The projected CAGR for the next 4 years is -97%.

9%
Past Growth
-97%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biotoxtech Co Ltd

Operating Income forecast
is not available for
Biotoxtech Co Ltd

Net Income
Forecast

Net Income Estimate
Biotoxtech Co Ltd

Net Income forecast
is not available for
Biotoxtech Co Ltd

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Biotoxtech Co Ltd's stock price target?
Price Target
15 000 KRW

According to Wall Street analysts, the average 1-year price target for Biotoxtech Co Ltd is 15 000 KRW .

What is Biotoxtech Co Ltd's Revenue forecast?
Projected CAGR
-97%

For the last 8 years the compound annual growth rate for Biotoxtech Co Ltd's revenue is 9%. The projected CAGR for the next 4 years is -97%.